| (in millions $) | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $6929 | $7371 | $7448 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $540291 | $531358 | $700358 | $727365 |
| Current liabilities | ||||
| Accounts payable | $2682 | $11442 | $12189 | $11955 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $128564 | $11442 | $15260 | $15132 |
| Long term debt | $151261 | $157235 | $162605 | $158010 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $486225 | $486229 | $657091 | $681523 |
| Shareholders' equity | ||||
| Retained earnings | $36059 | $23632 | $25025 | $29059 |
| Other shareholder equity | -$20607 | -$16850 | -$16265 | -$17544 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $148376.9 | $102541.2 | ||
| Short term investments | ||||
| Net receivables | $38334.67 | $35879.71 | ||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $6929 | $7305 | $7376 | $7832 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $531358 | $755833 | $859489.8 | $792412.4 |
| Current liabilities | ||||
| Accounts payable | $11442 | $17029 | $23095.09 | $25849.94 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $11442 | $46788 | $54247 | $58571 |
| Long term debt | $157235 | $140413 | $171815.4 | $152993 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $486229 | $711879 | $813688.9 | $748414.3 |
| Shareholders' equity | ||||
| Retained earnings | $23632 | $31064 | $35020.75 | $30833.12 |
| Other shareholder equity | -$16850 | -$21339 | -$24409.72 | -$20329.94 |
| Total shareholder equity | ||||
| (in millions $) | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3804 | $3645 | ||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $3698 | $419 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$4034 | -$1593 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $22696 | $23880.1 | $22630.15 | |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1026 | $854.35 | $1303.42 | |
| Interest expense | $8501.87 | $13252.59 | ||
| Net income | ||||
| Net income | -$1650 | $2846.76 | $3441.22 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $55542 | $4668 | $3683 | $14495 |
| Financing activities | ||||
| Dividends paid | -$280 | -$280 | -$280 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$163883 | -$24839 | -$5794 | -$6559 |
| Effect of exchange rate | -$1819 | -$813 | $2 | -$159 |
| Change in cash and equivalents | -$96340 | -$15627 | -$5346 | $3132 |
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
|---|---|---|---|---|
| Net income | $2843.56 | $3447.26 | ||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$6947.83 | -$18543.76 | ||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $55542 | -$10082 | $17784.49 | -$1334.62 |
| Financing activities | ||||
| Dividends paid | -$280 | -$257 | -$763.69 | -$700.52 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$163883 | -$47 | $31720.68 | $22333.23 |
| Effect of exchange rate | -$1819 | -$1103 | -$2844.62 | -$610.95 |
| Change in cash and equivalents | -$96340 | $25706 | $39712.72 | $1843.91 |
|
Is BNP Paribas SA (BNPQY) the Best European Bank Stock to Buy According to...
Insider Monkey · via Yahoo Finance
27 Jan 2025
|
|
BNP Slumps as Lending Headwinds Linger, Equities Miss
Bloomberg · via Yahoo Finance
31 Oct 2024
|
|
AXA IM Trims French Bank Stocks With Bond Risk a Lasting Trend
Bloomberg · via Yahoo News
19 Jun 2024
|
|
BNP Paribas (BNPQY) in Talks to Form Asset Management JV With Axa
Zacks · via Yahoo Finance
19 Jun 2024
|
|
AXA SA's Dividend Analysis
GuruFocus.com via Yahoo Finance
26 Apr 2024
|
|
AXAHY vs. ZURVY: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance
13 Mar 2024
|
|
Is Axa (AXAHY) Outperforming Other Finance Stocks This Year?
Zacks via Yahoo Finance
11 Mar 2024
|
|
AXAHY vs. ZURVY: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Finance
26 Feb 2024
|
|
AXAHY or ZURVY: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance
28 Jan 2024
|
|
AXAHY vs. ZURVY: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance
11 Jan 2024
|
| Market cap | $158.86B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 3.86B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |